Carbamic Acid

Carbamic Acid

SCHEMBL28763111

CCOc1ccc(Oc2ccc(S(=O)(=O)N3CCc4ccccc4C3)cc2)cc1.NC(=O)O

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
PKM P14618 2/20 0.59
AKR1C3 P42330 2/20 0.58
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
KDM4E B2RXH2 3/20 0.57
MAPT P10636 3/20 0.57
TSHR P16473 1/20 0.56
ALOX5 P09917 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.52
NPSR1 Q6W5P4 2/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C19 P33261 1/20 0.52
ALDH1A1 P00352 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.51
HPGD P15428 1/20 0.51
GAA P10253 2/20 0.50
RAB9A P51151 2/20 0.50
NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL27675490 0.88 SMN1; SMN2 (0.54) LMNAPKMAKR1C3MEN1KMT2A
Carbamic Acid SCHEMBL27675440 0.87 AKR1C3 (0.62) LMNAAKR1C3MEN1KMT2AKDM4E
Carbamic Acid SCHEMBL27693832 0.86 KMT2A (0.73) PKMAKR1C3MEN1KMT2AKDM4E
Carbamic Acid SCHEMBL27675445 0.86 AKR1C3 (0.61) AKR1C3MEN1KMT2AKDM4EMAPT
Carbamic Acid SCHEMBL4693159 0.83 AKR1C3 (0.58) AKR1C3MEN1KMT2AKDM4EMAPT
SCHEMBL5439640 0.76 MMP1 (0.50) LMNAPKMMEN1KMT2AMAPT
SCHEMBL5430809 0.76 MMP1 (0.50) LMNAPKMMEN1KMT2AMAPT
SCHEMBL5435833 0.76 MMP1 (0.50) LMNAPKMMEN1KMT2AMAPT
SCHEMBL23081190 0.75 AKR1C3 (0.78) AKR1C3MEN1KMT2AKDM4EMAPT
SCHEMBL693455 0.74 KMT2A (1.00) AKR1C3MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101006059-A Substituted tetrahydroisoquinolines for use as MMP inhibitors, method for the production thereof, and use thereof in the form of medicaments SANOFI AVENTIS DEUTSCHLAND (DE) 2007-07-25 CN disclosed